Related Experiment Video

Updated: Jul 7, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Blood glucose dynamics

Farbod N Rahaghi1, David A Gough

  • 1Department of Bioengineering, University of California San Diego, La Jolla, California 92093-0412, USA.

Diabetes Technology & Therapeutics
|February 12, 2008
PubMed

Insights

Understanding blood glucose dynamics is key for diabetes management. New analysis methods reveal distinct time scales of glucose variation in healthy individuals, offering insights into diabetes progression and treatment targets.

Area of Science:

  • Endocrinology
  • Biomedical Engineering
  • Computational Biology

Background:

  • Blood glucose concentration measurement is crucial for diabetes diagnosis and treatment.
  • Limited availability of continuous or high-frequency glucose data has hindered the study of blood glucose dynamics.
  • Existing glucose monitoring relies on discrete measurements, with few reference datasets from non-diabetic individuals.

Purpose of the Study:

  • To develop and demonstrate new analytical methods for characterizing blood glucose dynamics.
  • To propose a patient profiling system based on glucose variability.
  • To identify and analyze the time scales of blood glucose variations.

Main Methods:

  • Analysis of continuous or frequently sampled glucose measurement data.
  • Development of novel algorithms for characterizing glucose excursions.
  • Implementation of a patient profiling system.

Main Results:

  • Demonstration of several approaches for characterizing blood glucose dynamics.
  • Proposal of a patient profiling system.
  • Identification of four distinct time scales of blood glucose variations in non-diabetic individuals.
  • Observation that these time scales are altered or absent in individuals with diabetes.

Conclusions:

  • Blood glucose dynamics offer valuable information for diabetes diagnosis and treatment.
  • Advanced analytical methods are needed to fully utilize new glucose measurement data.
  • Characterizing glucose variability and time scales can lead to personalized diabetes management strategies.

More Related Videos

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas04:41

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas

Published on: July 25, 2025

Simple Continuous Glucose Monitoring in Freely Moving Mice03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...